loading
Precedente Chiudi:
$10.96
Aprire:
$11.26
Volume 24 ore:
11,921
Relative Volume:
0.09
Capitalizzazione di mercato:
$270.83M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+7.66%
1M Prestazione:
+7.97%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$10.74
$11.52
Intervallo di 1 settimana:
Value
$10.00
$11.57
Portata 52W:
Value
$9.68
$17.31

Artiva Biotherapeutics Inc Stock (ARTV) Company Profile

Name
Nome
Artiva Biotherapeutics Inc
Name
Telefono
(858) 267-4467
Name
Indirizzo
5505 MOREHOUSE DRIVE, SAN DIEGO
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ARTV's Discussions on Twitter

Confronta ARTV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ARTV 11.31 270.83M 0 0 0 0.00
VRTX 449.35 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.22 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.51 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.60 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.00 24.89B 3.30B -501.07M 1.03B 11.54

Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Iniziato Cantor Fitzgerald Overweight
2024-08-13 Iniziato Jefferies Buy
2024-08-13 Iniziato Needham Buy
2024-08-13 Iniziato TD Cowen Buy
2024-08-13 Iniziato Wedbush Outperform

Artiva Biotherapeutics Inc Borsa (ARTV) Ultime notizie

pulisher
Nov 18, 2024

Cantor Fitzgerald Forecasts ARTV FY2024 Earnings - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Cantor Fitzgerald Weighs in on ARTV FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

Wedbush Has Bearish Estimate for ARTV FY2024 Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Wedbush Lowers Earnings Estimates for Artiva Biotherapeutics - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Needham & Company LLC Reiterates Buy Rating for Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Issues Quarterly Earnings Results, Misses Estimates By $0.24 EPS - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Artiva Biotherapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Earns Buy Rating from Needham & Company LLC - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Artiva Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 11, 2024

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Artiva Bio to Present at Jefferies Healthcare Conference, Spotlight on Cell Therapy Pipeline | ARTV Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 05, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) vs. Iovance Biotherapeutics (NASDAQ:IOVA) Critical Review - Defense World

Nov 05, 2024
pulisher
Oct 27, 2024

Cell therapy developer Artiva refiles for a $100M IPO - MSN

Oct 27, 2024
pulisher
Oct 23, 2024

Artiva Biotherapeutics appoints new board member By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors - ForexTV.com

Oct 23, 2024
pulisher
Oct 22, 2024

Artiva Biotherapeutics, Inc. Appoints Alison Moore as an Independent Member of Its Board of Directors - Marketscreener.com

Oct 22, 2024
pulisher
Oct 22, 2024

Artiva Biotherapeutics appoints new board member - Investing.com

Oct 22, 2024
pulisher
Oct 15, 2024

Artiva, Century, others extend natural-killer autoimmune push - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Stock Price Down 5.4%Time to Sell? - MarketBeat

Oct 15, 2024
pulisher
Sep 28, 2024

Wall Street SWOT: Artiva Biotherapeutics stockNK cell pioneer targets autoimmune market By Investing.com - Investing.com South Africa

Sep 28, 2024
pulisher
Sep 23, 2024

The Attractiveness of Investing In Artiva Biotherapeutics Inc (ARTV) is Growing - Knox Daily

Sep 23, 2024
pulisher
Sep 22, 2024

Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.

Sep 22, 2024
pulisher
Sep 21, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Trading 6.2% Higher - MarketBeat

Sep 21, 2024
pulisher
Sep 10, 2024

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference - GlobeNewswire

Sep 10, 2024
pulisher
Aug 29, 2024

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Aug 29, 2024
pulisher
Aug 21, 2024

Artiva Biotherapeutics, Inc.’s (NASDAQ:ARTV) Quiet Period Will End on August 28th - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Artiva Biotherapeutics, Inc.'s Quiet Period Set To Expire on August 28th (NASDAQ:ARTV) - MarketBeat

Aug 21, 2024
pulisher
Aug 16, 2024

Brokers Issue Forecasts for Artiva Biotherapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ARTV) - MarketBeat

Aug 16, 2024
pulisher
Aug 15, 2024

Analysts Set Expectations for Artiva Biotherapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:ARTV) - Defense World

Aug 15, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Stock Quotes, Forecast and News Summary - Benzinga

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch - Benzinga

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Receives New Coverage from Analysts at TD Cowen - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Needham & Company LLC Initiates Coverage on Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Wedbush Initiates Coverage on Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Coverage Initiated by Analysts at Cantor Fitzgerald - Defense World

Aug 13, 2024
pulisher
Aug 12, 2024

Non-Hodgkin Lymphoma Drugs Pipeline 2024 | Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc - Barchart

Aug 12, 2024
pulisher
Aug 06, 2024

July IPOs to Watch in Tech, Biotech, Food Security and Transportation - Investorideas.com newswire

Aug 06, 2024
pulisher
Jul 28, 2024

Insider Buying in These 2 IPOs Is Huge, Plus Financial CEOs Pick Up Shares - 24/7 Wall St.

Jul 28, 2024
pulisher
Jul 28, 2024

Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal - Seeking Alpha

Jul 28, 2024
pulisher
Jul 23, 2024

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Director Yong-Jun Huh Buys 2,083,332 Shares - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Major Shareholder Global Strategic Fund I. Venbio Purchases 416,666 Shares - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

VenBio fund acquires $5m in Artiva Biotherapeutics stock By Investing.com - Investing.com Australia

Jul 23, 2024
pulisher
Jul 22, 2024

VenBio fund acquires $5m in Artiva Biotherapeutics stock - Investing.com India

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics sees major stock purchases by GC Corp entities - Investing.com South Africa

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics director Yong-Jun Huh buys $25m in IPO By Investing.com - Investing.com South Africa

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics director Yong-Jun Huh buys $25m in IPO - Investing.com India

Jul 22, 2024

Artiva Biotherapeutics Inc Azioni (ARTV) Dati Finanziari

Non sono disponibili dati finanziari per Artiva Biotherapeutics Inc (ARTV). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):